| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 59,038 | 59,868 | 59,256 | 62,500 | | Cost of Revenue | 8,556 | 9,786 | 10,380 | 12,238 | | | Gross Profit |
-
| 50,082 | 48,876 | 50,262 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 33,328 | 33,148 | 32,528 | 39,481 | | Non Recurring |
-
|
-
|
-
| 71 | | Others | 3,151 | 6,921 | 5,366 | (2,290) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 10,013 | 10,982 | 13,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 14,003 | 10,013 | 10,982 | 13,000 | | Interest Expense | 491 | 493 | 501 | 537 | | Income Before Tax | 13,512 | 9,520 | 10,481 | 12,463 | | Income Tax Expense | 4,122 | 3,260 | 3,356 | 4,394 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,390 | 6,260 | 7,125 | 8,069 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,390 | 6,260 | 7,125 | 8,069 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,390 | $6,260 | $7,125 | $8,069 |
|
0.51% Nasdaq 
Income Statement
